Related Experiment Video
Updated: Sep 27, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
GOC Conversations About LVAD Deactivation in Destination Therapy and Bridge-to-Candidacy Decedents
Eilann C Santo1, Hanna-Riikka Lehto2, Yilong Peng3
1Division of Adult Palliative Care, Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Division of Palliative Medicine, Brigham & Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Context:
Patients implanted with a left ventricular assist device (LVAD) as destination therapy (DT) or bridge-to-candidacy (BTC) have no established path off the device, making eventual deactivation likely. Documentation of goals-of-care (GOC) conversations addressing potential LVAD deactivation remains poorly described.
Objective:
To characterize the prevalence, timing, and clinical setting of documented GOC conversations addressing potential LVAD deactivation among DT and BTC decedents.
Methods:
Single-center, retrospective cohort study of DT and BTC LVAD patients who died between July 1, 2015-July 1, 2024 at a tertiary academic center with embedded palliative care. Clinical and death-related variables came from the Interagency Registry for Mechanically Assisted Circulatory Support. GOC conversations addressing potential deactivation were identified through structured electronic health record review using a keyword library.
Results:
Among 45 decedents, 35 (77.8%) had at least one documented deactivation conversation (79 total). Median time from first conversation to death was 20 days. Median time from implantation to first conversation was 566 days (IQR 52-1,659). Among first conversations, 40% occurred within 7 days of death; only 2 preceded implantation. Most were inpatient (87.3%) and authored by palliative care clinicians (78.5%). Palliative care was involved with 82.2% of patients, yet 10.8% had no documented deactivation conversation and 13.3% died in hospice.
Conclusions:
Documented GOC conversations addressing potential LVAD deactivation were not universal and typically first occurred near death, despite broad palliative care availability and a median of 566 days on device. Conversations occurred primarily during acute decline, leaving limited opportunity for preparation earlier in the course of support.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
05:18Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Peripheral Artery Disease V: Postoperative Nursing Management
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Heart Failure V: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy